Trials / Completed
CompletedNCT00540215
GLP-2 (Glucagonlike Peptide-2) and Blood Flow
The Role of GLP-2 in Univercal Changes in Blood Flow in Humans
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Glostrup University Hospital, Copenhagen · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
It is the study aim to investigate the effect of glp-2 on blood flow in humans. we wish to study eventual changes in renal blood flow, carotic blood flow and cardiac out put. GLP-2 will be administered subcutaneously, and the effect monitored by doppler ultra sound scannings and cotinuesly measuring of cardiac out put and blood pressure. The study will include 15 healhty volunteers, 10 wil receive 450 nmol GLP-2 and 5 will receive 1 ml of isotonic saline (as baseline reference).
Detailed description
se the above
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Glucagonlike peptide | 450 nmol native form, synthetic |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-01-01
- Completion
- 2008-02-01
- First posted
- 2007-10-05
- Last updated
- 2011-02-11
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00540215. Inclusion in this directory is not an endorsement.